UBC Medical Indonesia Tbk. vs Sarana Mitra Luas Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp148 (market cap 576.7B, 3.48M 24h volume), while Sarana Mitra Luas Tbk. trades at Rp318 (market cap 2.77T, 21.89M 24h volume). The key difference: Sarana Mitra Luas Tbk. is far larger — about 4.8× UBC Medical Indonesia Tbk.'s market cap, and Sarana Mitra Luas Tbk. is more actively traded (21.89M versus 3.48M). Which is the better fit depends on your goals.
| LABS | SMIL | |
|---|---|---|
Market Cap | 576.7B | 2.77T |
Volume | 3.48M | 21.89M |
Lot | 34.82K | 218.92K |
Turnover | 522.79M | 6.89B |
Average Price | 150.13 | 314.64 |
Value | 522.79M | 6.89B |
Indicative Equilibrium Price | 148 | 318 |
Indicative Equilibrium Volume | 350 | 11.02K |
Trailing returns across standard periods
Latest headlines on both assets
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →PT Sarana Mitra Luas Tbk (the Company) was established on Sep 28, 2006 based on Notarial Deed No. 06 of Fransiska Bonita Maya Dwi Tanti, S.H., notary in Bekasi. The Company started its commercial operations in 2006.
Read more on SMIL →